U.S., Feb. 20 -- ClinicalTrials.gov registry received information related to the study (NCT07420361) titled 'Lutein Iontophoresis in Intermediate AMD and Reticular Pseudodrusen - a Retrospective Study' on Feb. 01.
Brief Summary: There is limited data available on the efficacy and safety of Transscleral Lutein Iontophoresis (TSLI) in patients with in-termediate age-related macular degeneration (iAMD) and reticular pseudodrusen (RPD).
This retrospective multicentre study evaluated the functional and morphological outcomes of TSLI in patients with stage 2 and stage 3 iAMD with RPD. Autofluorescence (AF), Optical Coherence Tomography (OCT), Best Corrected Visual Acuity (BCVA), Intraocular Pressure (IOP), Macular Sensitivity (MS) and adverse e...